Once-Daily QVA149 Demonstrates Superior Outcomes in COPD Patients Previously Treated With Fixed-Dose Long-Acting β2-Agonist/Inhaled Corticosteroid (LABA/ICS): The ILLUMINATE Study
- Resource Type
- Abstract
- Source
- In
Chest March 2014 145(3) Supplement:424A-424A - Subject
- Language
- ISSN
- 0012-3692